Granules India Limited on Wednesday disclosed that njay Kumar has tendered his resignation from the role of Chief Strategy Officer, effective August 13, 2026. Kumar will assume the position of Chief Executive Officer at Ascelis Peptides Private Limited, the company’s wholly owned subsidiary, in what the firm describes as an internal transfer decided by management.
In a resignation letter addressed to the Chairman & Managing Director, Kumar thanked the board and the leadership team for their support and guidance during his tenure. The note underscores a leadership transition at the corporate-strategy level as Granules doubles down on its broader strategic agenda and the growth of its peptide-focused operations through the subsidiary.
Industry observers will note that such internal moves can realign strategic oversight across the parent and its units, with Granules likely to appoint a successor to lead the Chief Strategy Office. The development highlights Granules India’s approach to nurturing internal leadership talent while continuing to push forward with its growth plans across its portfolio.
With Kumar moving into the CEO role at Ascelis Peptides, Granules India will be keen to maintain continuity in strategic execution while it fills the leadership gap at the top of its strategy function. The announcement marks a notable milestone in the ongoing evolution of Granules’ leadership lineup.